Ophthalmic Drug Delivery63

Issue No #63 January 27th, 2016

Issue 63 - Jan 2016

Inside the magazine

A TOPICAL OCULAR RING DESIGNED TO REPLACE GLAUCOMA EYE DROPS

Anne Brody Rubin

A TOPICAL OCULAR RING DESIGNED TO REPLACE GLAUCOMA EYE DROPS

Anne Brody Rubin introduces ForSight VISION5's ring-shaped ocular insert containing prostaglandin for the lowering of intra-ocular pressure in glaucoma.

OPSISPORIN: A LONG-ACTING DRUG DELIVERY APPROACH FOR UVEITIS

OPSISPORIN: A LONG-ACTING DRUG DELIVERY APPROACH FOR UVEITIS

Here, Paul Seaman and Daniel Palmer discuss Midatech Pharma’s next generation treatments for auto-immune ocular diseases, which use a combination of innovative, sustained-release drug products.

NEW SOLUTIONS FOR OPHTHALMIC DRUG DELIVERY USING BIODEGRADABLE SILICA MATRIX

Dr Mika Jokinen

NEW SOLUTIONS FOR OPHTHALMIC DRUG DELIVERY USING BIODEGRADABLE SILICA MATRIX

Mika Jokinen, Cora Griffin, and Lasse Leino, PhD describe the novel opportunities that biodegradable silica matrix technology offers to ophthalmic drug delivery.

IMPROVING OPHTHALMIC DRUG DELIVERY WITH NOVEL EMULSION TECHNOLOGIES

Robin de Bruijn

IMPROVING OPHTHALMIC DRUG DELIVERY WITH NOVEL EMULSION TECHNOLOGIES

Robin de Bruijn and Frank de Jong describe EmulTech’s ET4ME micro-encapsulation process, and its suitability as a particle formation technology for enhancing and enabling ophthalmic injectables.

USING INTELLIGENT DESIGN TO DELIVER SAFE MULTI-DOSE EYE DROPS

USING INTELLIGENT DESIGN TO DELIVER SAFE MULTI-DOSE EYE DROPS

Ms Fanny Sellier, explains how the intelligent design of multi-dose bottles provides a viable means of delivering safe, preservative-free eye drops.

SUSTAINED-RELEASE OCULAR DELIVERY TECHNOLOGIES

Michael O'Rourke

SUSTAINED-RELEASE OCULAR DELIVERY TECHNOLOGIES

Michael O'Rourke discusses the advances in the development and launching of sustained-release ocular drug delivery systems seen in recent years.

SCALEABILITY OF MICRO INTRAOCULAR IMPLANTS AND DEVICES

SCALEABILITY OF MICRO INTRAOCULAR IMPLANTS AND DEVICES

Donna Bibber discusses some of these micro-intraocular implants and devices and the scalability challenges associated with each, from the perspective of a plastics engineer.

THERAPY WITHOUT DROPS: A REALITY

THERAPY WITHOUT DROPS: A REALITY

Chris Muller and Deepank Utkhede introduce Mati Therapeutics' Evolute^® ocular delivery system, a non-invasive, sustained-release platform that combines a novel punctal plug with a sustained release drug eluting core.

INTRODUCING OCUSURF™ NANOSTRUCTURED EMULSION AS A 505(B)(2) STRATEGY

Dr Shikha P Barman

INTRODUCING OCUSURF™ NANOSTRUCTURED EMULSION AS A 505(B)(2) STRATEGY

Shikha P Barman describes how Integral Biosystems is developing a series of ophthalmic products with its OcuSurf platform.

Top